Cargando…

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy

Mostrar otras versiones (1)

BACKGROUND: Sphingosine-1-phosphate receptor (S1P) modulators and antiCD20 therapies impair humoral responses to SARS-CoV-2 mRNA vaccines. Whether disease modifying therapies (DMTs) for multiple sclerosis (MS) also impact T cell immune response to vaccination is unknown. METHODS: In 101 people with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gadani, Sachin P., Reyes-Mantilla, Maria, Jank, Larissa, Harris, Samantha, Douglas, Morgan, Smith, Matthew D., Calabresi, Peter A., Mowry, Ellen M., Fitzgerald, Kathryn C., Bhargava, Pavan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404904/ https://www.ncbi.nlm.nih.gov/pubmed/34462762 http://dx.doi.org/10.1101/2021.08.23.21262472

Ejemplares similares

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy
por: Gadani, Sachin P., et al.
Publicado: (2021)

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
por: Fitzgerald, Kathryn C., et al.
Publicado: (2021)

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis
por: Fitzgerald, Kathryn C., et al.
Publicado: (2022)

Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
por: Bhargava, Pavan, et al.
Publicado: (2018)

A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
por: Newsome, Scott D., et al.
Publicado: (2023)

Peripheral T-Cells, B-Cells, and Monocytes from Multiple Sclerosis Patients Supplemented with High-Dose Vitamin D Show Distinct Changes in Gene Expression Profiles
por: Kim, Dohyup, et al.
Publicado: (2022)

BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
por: Gupta, Kanak, et al.
Publicado: (2023)

Obesity's role in MS: An intervention target with possible interactions
por: Fitzgerald, Kathryn C., et al.
Publicado: (2020)

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
por: Vasileiou, Eleni S., et al.
Publicado: (2022)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials
por: Bhargava, Pavan, et al.
Publicado: (2015)

Early Aggressive Treatment Approaches for Multiple Sclerosis
por: Simpson, Alexandra, et al.
Publicado: (2021)

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Plasma lipidomics of monozygotic twins discordant for multiple sclerosis
por: Penkert, Horst, et al.
Publicado: (2020)

Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis
por: Keller, Jennifer L., et al.
Publicado: (2022)

Acute Necrotizing Encephalitis as an Early Manifestation of COVID-19
por: Gadani, Sachin, et al.
Publicado: (2022)

Retinal measurements predict 10‐year disability in multiple sclerosis
por: Rothman, Alissa, et al.
Publicado: (2019)

Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis
por: Jennum, Poul J., et al.
Publicado: (2016)

Shedding light on IL-33 in the eye
por: Gadani, Sachin P., et al.
Publicado: (2016)

High-dose vitamin D(3) supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
por: Cassard, Sandra D., et al.
Publicado: (2023)

Dimethyl fumarate alters B‐cell memory and cytokine production in MS patients
por: Smith, Matthew D., et al.
Publicado: (2017)

Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
por: Baranzini, Sergio E., et al.
Publicado: (2010)

DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis
por: Souren, Nicole Y., et al.
Publicado: (2019)

Discordant Supramolecular Fibres Reversibly Depolymerised by Temperature and Light
por: Gerth, Marieke, et al.
Publicado: (2020)

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
por: Sabatino, Joseph J., et al.
Publicado: (2019)

Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease
por: Kim, Yaewon, et al.
Publicado: (2022)

Humoral immune activation in amyotrophic lateral sclerosis patients
por: Rentzos, Michael, et al.
Publicado: (2013)

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study
por: Moser, Tobias, et al.
Publicado: (2022)

Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
por: Nicolas, Philippe, et al.
Publicado: (2022)

Discord for dummies
por: Morris, Tee
Publicado: (2020)

Multiple sclerosis management during the COVID-19 pandemic
por: Moss, Brandon P, et al.
Publicado: (2020)

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
por: Nourbakhsh, Bardia, et al.
Publicado: (2018)

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis
por: Bernitsas, Evanthia, et al.
Publicado: (2017)

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis()
por: Novak, Frederik, et al.
Publicado: (2021)

Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis
por: Achtnichts, Lutz, et al.
Publicado: (2021)

Associations of sNfL with clinico‐radiological measures in a large MS population
por: Sotirchos, Elias S., et al.
Publicado: (2022)

Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression
por: Tarr, Ingrid S., et al.
Publicado: (2019)

Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets
por: Ramos, Paula S., et al.
Publicado: (2019)

Promising treatments of tomorrow for multiple sclerosis
por: Harrison, Daniel M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j79g8ctand9qbuumqeo67mgvuk